Navigation Links
Patients More Willing To Use Self-Injectable HIV Therapy Than Anticipated

Recent study shows that HIV patients are more willing to consider and use self-injectable therapy than many physicians anticipate // .

Initial results from the OpenMind study, the largest behavioural study to look at both patients' and physicians' perceptions of HIV care in treatment-experienced patients, were revealed today at EACS.

The findings are anticipated to help physicians implement improved care to HIV patients and help pave the way for better acceptance and integration of other new innovative drugs such as monoclonal antibodies that are increasingly being developed for the management of HIV and other diseases.

The study was conceived to look at attitudes to FUZEON (enfuvirtide), the first approved HIV fusion inhibitor, and an important option for treatment-experienced patients who face HIV resistance. FUZEON presents unique challenges because it is the first self-injectable antiretroviral whereas all other treatments are oral.

It was found that 76% of patients would consider using a self-injectable HIV therapy if their physician recommended it. However, only 28% of patients who are potentially eligible for FUZEON had actually discussed this injectable option with their physicians. Only 10% of eligible patients were currently prescribed FUZEON, despite the fact that it is recommended in key international HIV treatment guidelines.

This study also identifies some of the main reasons why many physicians may be reluctant to prescribe a treatment of proven efficacy and safety. The reasons include; the physicians' perception that patients would be reluctant to use a self-injectable therapy, the physicians' opinion that the patient would not be able to incorporate FUZEON into their lifestyle and the potential misconception that FUZEON is not appropriately recommended in guidelines.

Rob Horne, Professor of Psychology at the University of Brighton and OpenMind study author, said, "These new insights from th
'"/>




Page: 1 2

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
(Date:5/27/2015)... The new http://www.carsonenergy.com includes ... should consider oil and gas investing, the substantial tax ... drilled, industry news, IRA investing, definitions and acronyms, info-graphics ... knowledge and experience is now in one central location, ... able to access 24 hours a day, 7 days ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 The ... announce a partnership to provide CMSA's Career and ... This collaboration seeks to strengthen the case/care management ... CMSA’s CKP program. The mutually beneficial agreement provides ... individual skills of talent in the healthcare, scientific ...
(Date:5/27/2015)... Coco Libre announced today that artists and audiences at ... Coconut Water to quench their thirst during the festival May ... artist greenrooms, corporate skyboxes and concessions areas at the venue. ... festival shuttle buses. , “We’re excited to have Coco ... of Strategic Partnerships for Latitude 38 Entertainment, producer of the ...
(Date:5/27/2015)... Meadows, IL (PRWEB) May 27, 2015 ... release of its SonarMD Platform, a first-of-its ... monitoring and managing patients with chronic gastrointestinal ... Kosinski, MD, MBA, the application allows physicians ... visits through the ongoing use of electronic ...
(Date:5/27/2015)... 2015 SmarterSkin, http://www.smarterskindermatology.com , is taking ... test that makes it easier for patients to find skin ... , Dr. Sejal Shah is a cosmetic dermatologist based in ... offer the test. This revolutionary DNA test uses 16 genetic ... aging: , 1. Firmness and elasticity , 2. ...
Breaking Medicine News(10 mins):Health News:Carson Energy Launches Next Generation Investor Website 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:SmarterSkin Dermatology is Now Offering Skin DNA Analysis 2
... Universal Banking at the Heart of Tanzanian Bank,s,Expansion Plans, ... and services,company, today announces that CRDB Bank of Tanzania ... 1996, CRDB Bank is entering a period of renewed,expansion ... launch a fully,automated and integrated banking service and add ...
... review board, today announced that they have appointed Michael Malafronte to ... Malafronte brings to Quorum 24 years of executive experience with quality ... Michael will lead Quorum in continuous quality improvement. , ... ...
... families experience a high degree of interpersonal conflict have ... with Asian Americans overall, according to a new study ... tripled even among those who have never had a ... reported during a 2 p.m. (EDT) poster session, "Improving ...
... half of 26,000 students across 70 colleges and universities ... at least one episode of suicidal thinking at some ... surveyed reported having seriously considered attempting suicide and more ... least once in their lifetime. , Presenting Sunday at ...
... recent recall notice for the heart drug Digitek, the ... on how long the heart medication was being improperly ... manufacturer, some Digitek tablets may have been manufactured at ... a double dose of the drug, leading to an ...
... Statement Attributable to: Linda L. Kloss, MA, RHIA AHIMA Chief ... ... American Health Information,Management Association is excited to hear the Centers for ... as a significant step forward in the march toward the use ...
Cached Medicine News:Health News:CRDB Bases Growth Strategy on Misys BankFusion Platform 2Health News:CRDB Bases Growth Strategy on Misys BankFusion Platform 3Health News:Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration 2Health News:Suicide in Asian Americans 2Health News:Suicidal thoughts among college students more common than expected 2Health News:Suicidal thoughts among college students more common than expected 3Health News:Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity 2Health News:Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity 3
(Date:5/27/2015)... , May 27, 2015 /PRNewswire/ ... MXIM ) makes it easy to ... to monitor or control unsanitary reuse ... gamma-radiation-resistant, nonvolatile (NV) 1-Wire® memory. ... http://www.maximintegrated.com/en/products/digital/memory-products/DS28E80.html , Maxim,s ...
(Date:5/27/2015)...  Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce ... Financial Officer, will present at the Jefferies 2015 Global Healthcare ... New York City . The ... the Cambrex website at www.cambrex.com in the Investors ... available for 90 days after the live event concludes.  ...
(Date:5/27/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), a ... announced an upcoming poster presentation regarding its lead drug ... Oncology (ASCO) Annual Meeting, which is being held May ... . "I am impressed by the ... who have undergone treatment with aldoxorubicin across several cancer ...
Breaking Medicine Technology:Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 2Gamma-Radiation-Resistant Memory Provides Calibration and Protects from Unsanitary Reuse in Medical Disposables 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 2CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 4CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 5
... MIAMI , July 12 Fuisz Pharma today announced that ... Dye" (invented by Dr. Thomas Gruber )).  This patent covers the ... method to prevent the improper use of opiate derived drugs by visually ... , Fuisz ...
... Surgical Technology, Inc. recently expanded its Biologics Product Specialist program to provide ... that address bone and soft tissue repair. , ... Mr. Shane Ray , General Manager for ... innovative biologic products and to compete with well established biologic providers in ...
Cached Medicine Technology:Fuisz Pharma Announces Acquisition of Key Anti Opiate Abuse Patent to Complement its Anti Opiate Abuse Platform 2Pioneer® Surgical Expands Product Specialists to Support Growing Biologics Business 2
SCD Sequential Compression System Intermittent Pneumatic Compression...
Classic black cast boot with unisex styling...
The Multi-Purpose Medical-Surgical Shoe...
... enzyme-linked immunosorbent assay for the ... IgA-class antibodies to Gliadin in ... is intended to be used ... diagnosis of gastrointestinal disorders, manily ...
Medicine Products: